(2014). Prelim inary results from a Phase I/2 study of INCB024360 combined with ipilimumab in patients with melanoma. Presented at: Annual Meeting of the American Society of Clinical Onco logy; 2014 May 30-June 3, Chicago, IL. Hamid, O., H. Schmidt, et al.